Quebec City in 1994, Montreal in 2001, and Toronto in 2007!
Quebec City in 1994, Montreal in 2001 and Toronto in 2007!
TORONTO, CANADA, July 26, 2007-Over the past fourteen years Anapharm has established itself as a world class provider of clinical and bioanalytical services to international sponsors and offers strategically located operations in five Canadian cities. Most recently, we opened a 160-bed clinical facility in Toronto, Canada.
Toronto site features:
- Modern, efficient facilities;
- Over 40,000 sq ft, on the 6th floor with ample natural light and park views;
- Clinical site comprised of 4 spacious clinical units with a total capacity of 160 beds;
- Units can be combined in order to conduct larger studies;
- The clinic offers full clinical services and on-site Quality Assurance support. Project Management services continue to be offered at the same level of excellence as at our Quebec and Montreal sites. One of our bioanalytical sites is located nearby in Richmond Hill.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
